TAFERO
A fixed-dose tablet of emtricitabine 200 mg and tenofovir alafenamide 25 mg from Hetero (India), approved by India's DCGI.
- Product type
- Antiretroviral fixed-dose combination
- Ingredients
- Emtricitabine 200 mg, tenofovir alafenamide 25 mg
- Line-up / Units
- Tafero EM
- Form
- Tablets (30)
- Manufacturer
- Hetero Healthcare Ltd.
- Country of origin
- India
Key points
- FTC 200 mg + TAF 25 mg
- DCGI-approved, launched 2018
Contact us for pricing and terms